ACHV Share Price Performance
US$4.78
0.06 (1.27%)
Price US$4.78
Share PriceUS$4.78
Achieve Life Sciences, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 27 Fair Values set on narratives written by author
ACHV Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Achieve Life Sciences, Inc. Key Details
About ACHV
- Founded
- n/a
- Employees
- 25
- CEO
- WebsiteView website
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
